Evidence map›Paper›PMID 34650188›Full record

ArticleCommunications biology2021

Matrigel 3D bioprinting of contractile human skeletal muscle models recapitulating exercise and pharmacological responses.

Angela Alave Reyes-Furrer, Sonia De Andrade, Dominic Bachmann, Heidi Jeker, Martin Steinmann, Nathalie Accart, Andrew Dunbar, Martin Rausch, Epifania Bono, Markus Rimann and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. A review of 3D bioprinting for organoids.Medical review (2021) · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A bioprinted model of pregnant human uterine myometrium.Frontiers in bioengineering and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Angela Alave Reyes-FurrerMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Sonia De AndradeMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.ORCID 0000-0003-0900-5820
Dominic BachmannMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Heidi JekerMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Martin SteinmannAnalytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Nathalie AccartMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Andrew DunbarAnalytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Martin RauschAnalytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Epifania Bono3D Tissues and Biofabrication, Institute of Chemistry and Biotechnology (ICBT), Zurich University of Applied Sciences, Waedenswil, Switzerland.
Markus Rimann3D Tissues and Biofabrication, Institute of Chemistry and Biotechnology (ICBT), Zurich University of Applied Sciences, Waedenswil, Switzerland. markus.rimann@zhaw.ch.ORCID 0000-0002-4605-8190
Hansjoerg KellerMusculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland. hansjoerg.keller@novartis.com.ORCID 0000-0003-1127-5133
Novartis (Switzerland) · CHZHAW Zurich University of Applied Sciences · CHZHAW Zurich University of Applied Sciences · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key to enhance the low translatability of preclinical drug discovery are in vitro human three-dimensional (3D) microphysiological systems (MPS). Here, we show a new method for automated engineering of 3D human skeletal muscle models in microplates and functional compound screening to address the lack of muscle wasting disease medication. To this end, we adapted our recently described 24-well plate 3D bioprinting platform with a printhead cooling system to allow microvalve-based drop-on-demand printing of cell-laden Matrigel containing primary human muscle precursor cells. Mini skeletal muscle models develop within a week exhibiting contractile, striated myofibers aligned between two attachment posts. As an in vitro exercise model, repeated high impact stimulation of contractions for 3 h by a custom-made electrical pulse stimulation (EPS) system for 24-well plates induced interleukin-6 myokine expression and Akt hypertrophy pathway activation. Furthermore, the known muscle stimulators caffeine and Tirasemtiv acutely increase EPS-induced contractile force of the models. This validated new human muscle MPS will benefit development of drugs against muscle wasting diseases. Moreover, our Matrigel 3D bioprinting platform will allow engineering of non-self-organizing complex human 3D MPS.

Indexed as

BioprintingCaffeineCollagenDrug CombinationsElectric StimulationExerciseHumansImidazolesLamininMuscle ContractionMuscle, SkeletalPrinting, Three-DimensionalProteoglycansPyrazinesCaffeineCK-2017357CollagenDrug CombinationsImidazolesLamininmatrigelProteoglycansPyrazines

Identifiers

PMID34650188
PMCPMC8516940
OpenAlexW3207400420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.